-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kairos Pharma: Transaction to Add CL-273, a pan-EGFR Inhibitor, and CL-741, a Phase 1-Ready c-MET Inhibitor >KAPA

Dow Jones·02/26/2026 12:04:00

Please log in to view news